Sleep Disorders News

A drug administered through a nasal spray may be an alternative treatment option for patients with obstructive sleep apnea by improving upper airway collapsibility, according to a study published in CHEST.

The FDA has granted 510(k) clearance to a daytime-nighttime appliance, or DNA, to treat patients with mild to moderate obstructive sleep apnea, according to a manufacturer-issued press release.

Individuals with high body water mass appeared to have an increased risk for sleep apnea, possibly mediated by pathologic edema, according to a study published in Annals of the American Thoracic Society.

NASHVILLE, Tenn. — Many survivors of long-term COVID experience difficulties sleeping, but it is unclear whether these disturbances are helping or hurting their recovery, according to a speaker at the CHEST Annual Meeting.

There is still not enough evidence to make a recommendation for or against obstructive sleep apnea screening in asymptomatic adults, according to a statement from the U.S. Preventive Services Task Force.

NASHVILLE, Tenn. — Among patients undergoing a sleep study, two oxygenation benchmarks demonstrated utility as screening tools for predicting underlying cardiopulmonary disease, according to study results.

NASHVILLE, Tenn. — Patients with obstructive sleep apnea and lower household income had higher odds of acute myocardial infarction, all-cause mortality and cardiac arrest, according to data presented at the CHEST Annual Meeting.

More than half of hospitalized adults with HF have obstructive sleep apnea or central sleep apnea, with male sex, higher BMI, higher heart rate and more comorbidities predicting sleep-disordered breathing, researchers reported.

New data have linked more consistent use of CPAP treatment to lower risk for rehospitalization in older adults with obstructive sleep apnea and cardiovascular disease.

The Healio Editors compiled the most-read news in pulmonology posted in August.